Skinny Stack

Skinny Stack – AOD-9604 / MOTS-c / Tesamorelin Blend

Target Stubborn Fat. Sculpt Metabolic Health. Optimize GLP-1 Outcomes.

Overview:
The Skinny Stack is a cutting-edge peptide blend engineered to target hard-to-lose fat, improve metabolic flexibility, and support lean body composition—especially when used alongside GLP-1 therapies such as semaglutide or tirzepatide. Combining AOD-9604, MOTS-c, and Tesamorelin, this powerful trio attacks visceral and subcutaneous fat from multiple angles: growth hormone stimulation, mitochondrial activation, and lipolytic signaling.

Whether you’ve plateaued on a weight loss journey, want to accelerate body recomposition, or need a smart adjunct to your GLP-1 protocol, the Skinny Stack was designed to unlock results where other strategies stall.

Key Benefits:

• Targets Stubborn & Visceral Fat Deposits
• Enhances Mitochondrial Fat Oxidation & Metabolic Efficiency
• Supports Lean Muscle Preservation During Weight Loss
• Improves Insulin Sensitivity & Glucose Utilization
• Optimizes Outcomes from GLP-1 Agonists
• Helps Prevent Muscle Wasting on Calorie-Restricted Plans

What’s Inside the Stack?

🔥 AOD-9604

A modified fragment of human growth hormone (HGH) that stimulates lipolysis (fat breakdown) without increasing blood sugar or impacting IGF-1 levels.

• Specifically targets fat metabolism, especially abdominal and visceral fat
• Does not affect appetite or cause systemic GH-related side effects
• Enhances energy from fat stores without muscle breakdown

⚡ MOTS-c

A mitochondrial-derived peptide that acts as a cellular energy regulator, improving insulin sensitivity and increasing fat oxidation during calorie restriction.

• Boosts mitochondrial function and metabolic flexibility
• Enhances fat burning, even at rest
• Improves glucose tolerance and prevents diet-induced obesity in studies

💪 Tesamorelin

A growth hormone-releasing hormone (GHRH) analog clinically approved to reduce visceral adipose tissue (VAT), especially in abdominal regions.

• Reduces deep belly fat while preserving lean muscle
• Stimulates GH/IGF-1 axis for metabolic and body composition improvements
• Particularly effective when combined with GLP-1s for amplified results

Who Is It For?

• Patients on GLP-1 Therapy (Semaglutide, Tirzepatide, etc.) looking to enhance fat loss without additional appetite suppression
• Individuals with High Visceral Fat or Belly Fat Resistance
• Men & Women Focused on Body Recomposition
• Metabolic Optimization Patients with insulin resistance or sluggish fat-burning
• Fitness Clients Seeking Lean Mass Preservation While Cutting

Usage Protocol:

• Format: Injectable (subcutaneous)
• Cycle: 8–12 weeks or ongoing with physician guidance
• Dosing Schedule:
  • AOD-9604: Daily (AM)
  • MOTS-c: 2–3x per week
  • Tesamorelin: Daily or 5x/week (evening preferred)
• Stacking Options: Pairs perfectly with Semaglutide, Tirzepatide, or Liraglutide; also stackable with CJC-1295/Ipamorelin for enhanced GH output

Why Choose the Skinny Stack?

• Multi-pathway fat loss without overstimulating appetite control mechanisms
• Designed to preserve muscle and prevent metabolic slowdown
• Targets fat that GLP-1s often miss (visceral and stubborn deposits)
• Optimizes energy use, insulin response, and metabolic recovery
• Perfect for breaking plateaus and reshaping body composition

‍